Zhitong Finance App News, China Pharmaceutical (600056.SH) issued an announcement. Recently, Tianfang Pharmaceutical Co., Ltd. (hereinafter referred to as “Tianfang Pharmaceutical”), a wholly-owned subsidiary of the company, received the approval and issuance of clarithromycin tablets (hereinafter referred to as “this drug”) “Drug Supplement Application Approval Notice” from the China Drug Administration (hereinafter referred to as the “State Drug Administration”). The drug passed the consistent evaluation of the quality and efficacy of generic drugs.

Zhitong Finance App News, China Pharmaceutical (600056.SH) issued an announcement. Recently, Tianfang Pharmaceutical Co., Ltd. (hereinafter referred to as “Tianfang Pharmaceutical”), a wholly-owned subsidiary of the company, received the approval and issuance of clarithromycin tablets (hereinafter referred to as “this drug”) “Drug Supplement Application Approval Notice” from the China Drug Administration (hereinafter referred to as the “State Drug Administration”). The drug passed the consistent evaluation of the quality and efficacy of generic drugs.